Your browser doesn't support javascript.
loading
Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study.
Muwonge, Richard; Basu, Partha; Gheit, Tarik; Anantharaman, Devasena; Verma, Yogesh; Bhatla, Neerja; Joshi, Smita; Esmy, Pulikottil O; Poli, Usha Rani Reddy; Shah, Anand; Zomawia, Eric; Shastri, Surendra S; Pimple, Sharmila; Prabhu, Priya R; Hingmire, Sanjay; Chiwate, Aruna; Sauvaget, Catherine; Lucas, Eric; Malvi, Sylla G; Siddiqi, Maqsood; Sankaran, Subha; Kannan, Thiraviam Pillai Rameshwari Ammal; Varghese, Rintu; Divate, Uma; Vashist, Shachi; Mishra, Gauravi; Jadhav, Radhika; Tommasino, Massimo; Pillai, M Radhakrishna; Sankaranarayanan, Rengaswamy; Jayant, Kasturi.
Afiliação
  • Muwonge R; Screening Group, Section of Early Detection and Prevention, International Agency for Research on Cancer, Lyon, France.
  • Basu P; Screening Group, Section of Early Detection and Prevention, International Agency for Research on Cancer, Lyon, France.
  • Gheit T; Infections and Cancer Biology Group, Section of Infections, International Agency for Research on Cancer, Lyon, France.
  • Anantharaman D; Rajiv Gandhi Centre for Biotechnology, Poojappura, Thiruvananthapuram, Kerala, India.
  • Verma Y; Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok, Sikkim, India.
  • Bhatla N; Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
  • Joshi S; Jehangir Clinical Development Centre, Jehangir Hospital Premises, Pune, India.
  • Esmy PO; Christian Fellowship Community Health Centre, Ambillikai (near Oddanchathram), Dindigul District, Tamil Nadu, India.
  • Poli URR; Indian Institution of Public Health-Hyderabad, Public Health Foundation of India, Hyderabad, India.
  • Shah A; Gujarat Cancer & Research Institute (GCRI), M.P. Shah Cancer Hospital, Civil Hospital Campus, Asarwa, Ahmedabad, India.
  • Zomawia E; Civil Hospital, Aizawl, Mizoram, India.
  • Shastri SS; Department of Health Disparities Research, Division of Cancer Prevention and Population Sciences, University of Texas M.D. Anderson Cancer Centre, Houston, TX, United States of America.
  • Pimple S; Department of Preventive Oncology, Tata Memorial Center, Tata Memorial Hospital & Cancer Research Inst, Parel, Mumbai, India.
  • Prabhu PR; Rajiv Gandhi Centre for Biotechnology, Poojappura, Thiruvananthapuram, Kerala, India.
  • Hingmire S; Tata Memorial Centre Rural Cancer Project, Nargis Dutt Memorial Cancer Hospital, Barshi District Solapur, Maharashtra, India.
  • Chiwate A; Tata Memorial Centre Rural Cancer Project, Nargis Dutt Memorial Cancer Hospital, Barshi District Solapur, Maharashtra, India.
  • Sauvaget C; Screening Group, Section of Early Detection and Prevention, International Agency for Research on Cancer, Lyon, France.
  • Lucas E; Screening Group, Section of Early Detection and Prevention, International Agency for Research on Cancer, Lyon, France.
  • Malvi SG; Tata Memorial Centre Rural Cancer Project, Nargis Dutt Memorial Cancer Hospital, Barshi District Solapur, Maharashtra, India.
  • Siddiqi M; Cancer Foundation of India, Kolkata, West Bengal, India.
  • Sankaran S; Rajiv Gandhi Centre for Biotechnology, Poojappura, Thiruvananthapuram, Kerala, India.
  • Kannan TPRA; Rajiv Gandhi Centre for Biotechnology, Poojappura, Thiruvananthapuram, Kerala, India.
  • Varghese R; Rajiv Gandhi Centre for Biotechnology, Poojappura, Thiruvananthapuram, Kerala, India.
  • Divate U; Jehangir Clinical Development Centre, Jehangir Hospital Premises, Pune, India.
  • Vashist S; Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
  • Mishra G; Department of Preventive Oncology, Tata Memorial Center, Tata Memorial Hospital & Cancer Research Inst, Parel, Mumbai, India.
  • Jadhav R; Jehangir Clinical Development Centre, Jehangir Hospital Premises, Pune, India.
  • Tommasino M; Infections and Cancer Biology Group, Section of Infections, International Agency for Research on Cancer, Lyon, France.
  • Pillai MR; Rajiv Gandhi Centre for Biotechnology, Poojappura, Thiruvananthapuram, Kerala, India.
  • Sankaranarayanan R; Research Triangle Institute (RTI) International India, New Delhi, India.
  • Jayant K; Research Triangle Institute (RTI) International India, New Delhi, India.
PLoS One ; 15(12): e0244242, 2020.
Article em En | MEDLINE | ID: mdl-33373380
ABSTRACT
In context of the ongoing multi-centric HPV vaccine study in India, unvaccinated married women (N = 1484) aged 18-23 years were recruited in 2012-2015 as age-matched controls to the vaccinated women and followed up yearly. We assess type-specific prevalence, natural history and potential determinants of human papillomavirus (HPV) infection in these unvaccinated women. Cervical samples were collected yearly for at least four consecutive years. A Multiplex Type-Specific E7-Based polymerase chain reaction assay was used to detect 21 HPV types. HPV prevalence was 36.4% during 6 years. Most common HPV types were 16 (6.5%) and 31 (6.1%). Highest persistence were observed for HPV 35 (62.5%) and 52 (25%). New HPV acquisition rate was 5.6/1000 person-months of observation (PMO), highest for HPV 16 (1.1/1000 PMO). Type-specific clearance rates ranged between 2.9-5.5/100 PMO. HPV 16 and/or 18 infections were 41% (95% CI 4-63%) lower among women with 2-<3 years between marriage and first cervical sample collection compared to those with <2 years. HPV prevalence and acquisition rates in young Indian women were lower than their Western counterparts. HPV 16 infections being most common shows the importance and potential impact of HPV vaccination in India. Women with 2-3 years exposure had reduced risk possibly due to higher infections clearance.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Papillomaviridae / Comportamento Sexual / Vacinação / Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Papillomaviridae / Comportamento Sexual / Vacinação / Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article